Investors Watch List: Halozyme Therapeutics, Inc. (NASDAQ:HALO), Staples, Inc. (NASDAQ:SPLS), Columbia Sportswear Company (NASDAQ:COLM), Exelixis, Inc. (NASDAQ:EXEL), ManpowerGroup Inc. (NYSE:MAN)

Halozyme Therapeutics, Inc. (NASDAQ:HALO) belongs to Healthcare sector. Its net profit margin is -69.50% and weekly performance is 0.58%. On last trading day company shares ended up $17.35. Halozyme Therapeutics, Inc. (NASDAQ:HALO) distance from 50-day simple moving average (SMA50) is 11.05%. Halozyme Therapeutics, Inc. (NASDAQ:HALO), announced interim findings from the ongoing phase 2 clinical study of its investigational new drug PEGPH20 for the potential treatment of patients with metastatic pancreatic cancer.

Staples, Inc. (NASDAQ:SPLS) shares decreased -0.15% in last trading session and ended the day at $16.47. SPLS Gross Margin is 26.00% and its return on assets is 0.90%. Staples, Inc. (NASDAQ:SPLS) quarterly performance is -1.12%. Staples, Inc. (NASDAQ:SPLS) announced that “Staples Business Loans” has surpassed a million dollars of funding for small businesses. The quick and easy access to capital has helped more than 43 small businesses nationwide, ranging from a lunch wagon in Virginia to a medical writing company in Georgia to a construction service business in Ohio. The $1.5 million in loans is helping businesses expand, hire new employees and build for the future.

Columbia Sportswear Company (NASDAQ:COLM) ended the last trading day at $56.05. Company weekly volatility is calculated as 1.71% and price to cash ratio as 8.68. Columbia Sportswear Company (NASDAQ:COLM) showed a weekly performance of -0.99%. Columbia Sportswear Company (NASDAQ:COLM) announced the promotions of four senior leaders. Lisa Kulok, who joined the company in February 2008 and has served as Vice President of Global Marketplace Planning and Customer Operations since October 2009, is promoted to Senior Vice President of Global Supply Chain Operations. In this role, she will be responsible for the company’s global inventory planning, transportation logistics, distribution and account operations.
Exelixis, Inc. (NASDAQ:EXEL) belongs to Healthcare sector. Its weekly performance is 0.32%. On last trading day company shares ended up $3.15. Exelixis, Inc. (NASDAQ:EXEL) distance from 50-day simple moving average (SMA50) is 5.01%. Exelixis, Inc. (NASDAQ:EXEL) announced positive results from a phase 2 clinical study evaluating cabozantinib as a treatment for EGFR wild-type non-small cell lung cancer (NSCLC). The trial, Study E1512, is a randomized phase 2 trial by the ECOG-ACRIN Cancer Research Group of cabozantinib and erlotinib, alone or in combination, as second- or third-line therapy in patients with metastatic EGFR wild-type NSCLC.

ManpowerGroup Inc. (NYSE:MAN) shares moved down -0.90% in last trading session and ended the day at $84.65. MAN Gross Margin is 16.80% and its return on assets is 5.80%. ManpowerGroup Inc. (NYSE:MAN) quarterly performance is 5.21%. ManpowerGroup (NYSE:MAN), announced Monday that it has acquired the Australian and Singapore arm of Greythorn, a professional services and recruitment firm specialising in technology and finance. With this acquisition, Greythorn and its banking and finance subsidiary Marks Sattin, become wholly owned by ManpowerGroup Australia, operating under the Experis brand.

Leave a Reply

Your email address will not be published. Required fields are marked *